San Mateo, CA, United States of America

Scott E Smith

This inventor holds 1 USPTO granted patent and 9 published patent applications. Top assignee: Cygnus Therapeutic System. Active years: 1993.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Scott E. Smith: Innovator in Transdermal Drug Delivery Systems

Introduction

Scott E. Smith is a notable inventor based in San Mateo, California. He has made significant contributions to the field of transdermal drug delivery systems. His innovative work focuses on improving the efficiency and effectiveness of drug delivery through the skin.

Latest Patents

Scott E. Smith holds a patent for "Occlusive, elastomeric backing materials in transdermal drug delivery." This patent describes improved transdermal drug delivery systems that incorporate an occlusive, elastomeric backing layer that is preferably liquid-resistant. The systems utilize a single homogeneous sheet of elastomeric material with a moisture vapor transmission rate (MVTR) ranging from about 0.1 to 20 g/m²/hr and a Young's modulus between about 10⁴ to 10⁹ dynes/cm². Additionally, the patent outlines methods for making and using transdermal drug delivery devices that feature these advanced backing layers. Scott has 1 patent to his name.

Career Highlights

Scott E. Smith is associated with Cygnus Therapeutic Systems, where he has been instrumental in developing innovative drug delivery technologies. His work has contributed to advancements in the medical field, particularly in how medications are administered through the skin.

Collaborations

Scott has collaborated with Subbu S. Venkatraman, working together to enhance the capabilities of transdermal drug delivery systems. Their partnership has led to significant advancements in the technology.

Conclusion

Scott E. Smith is a pioneering inventor whose work in transdermal drug delivery systems has the potential to transform how medications are delivered. His innovative approaches and collaborations continue to push the boundaries of medical technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…